Pfizer's (PFE) Etrasimod Call Highlights Unmet Need Opportunity - BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham reiterated a Buy rating and $70.00 price target on Pfizer (NYSE: PFE) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
